期刊文献+

Pro-senescence neddylation inhibitor combined with a senescence activated β-galactosidase prodrug to selectively target cancer cells 被引量:2

原文传递
导出
摘要 Dear Editor,Targeting senescence therapy is a promising anticancer strategy by arresting the cell-cycle and inducing cellular senescence.However,senescent cells can promote malignancy and drug resistance.1,2 Thus,with the induction of senescence emerged as a viable therapeutic concept,it is important to consider how to eliminate those senescent cancer cells.
出处 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2022年第10期3645-3648,共4页 信号转导与靶向治疗(英文)
基金 supported by the National Natural Science Foundation of China(Grant Nos.81820108022,22177076,22037002) Innovation Program of Shanghai Municipal Education Commission(2019-01-07-00-10-E00056,2021-01-07-00-02-E00104) The Scientific and Technological Innovation Action Plan of Science and Technology Commission of Shanghai(20JC1411300) Shanghai Frontiers Science Center of Disease and Syndrome Biology of Inflammatory Cancer Transformation(2021KJ03-12) National Thirteenth Five-Year Science and Technology Major Special Project for New Drug and Development(2017ZX09304001) the Shanghai Frontier Science Research Base of Optogenetic Techniques for Cell Metabolism(2021 Sci&Tech 03-28) the Innovative Research Team of High-level Local Universities in Shanghai and the Chinese Special Fund for State Key Laboratory of Bioreactor Engineering(2060204).
关键词 viable cancer eliminate
作者简介 Shuaishuai Ni,contributed equally;Qian Liu,contributed equally;Xin Chen,contributed equally;Lele Ding,contributed equally;Correspondence:Jian Li(jianli@ecust.edu.cn)Correspondence:Lijun Jia(ljjia@shutcm.edu.cn)。
  • 相关文献

同被引文献8

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部